{
  "id": 20018404,
  "title": "Amdocs director Yvette Kanouff acquires $100,800 in ordinary shares",
  "url": "https://urgent.news/2026/11/14/amdocs-director-yvette-kanouff-acquires-100-800-in-ordinary-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-14T17:31:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/amdocs-director-yvette-kanouff-acquires-100800-in-ordinary-shares-93CH-5027434"
  },
  "original_language": "en",
  "account": "On November 9, 2026, Amdocs director Yvette Kanouff purchased 2,400 ordinary shares of the company at $42 per share, investing a total of $100,800. Subsequently, on the same day, she acquired an additional 6,058 ordinary shares at a price of $0.00 per share. Following these transactions, Ms. Kanouff now directly holds 32,658 ordinary shares, inclusive of shares subject to outstanding restricted stock units.\n\nThe insider purchase occurred amidst a challenging period for Amdocs shares, which are trading at $44.79, down 43% year-to-date and close to their 52-week low of $39.96. Despite the stock appearing undervalued according to InvestingPro analysis, the company is trading at a low P/E ratio of 9.53 and offers a dividend yield above 5%. The Pro Research Report suggests that management has been actively buying back shares, and the stock is currently in oversold territory.\n\nInvestors can further explore the company's prospects through the comprehensive Pro Research Report, which covers DOX and over 1,400 other US equities. Earlier this month, Amdocs reported its fiscal 2026 revenue of $4.7 billion, representing a 3.6% increase, and non-GAAP earnings per share of $7.41, up 6% from the previous year. Both figures met market expectations.\n\nHowever, fiscal 2027 guidance has drawn concerns, primarily due to a significant dispute with T-Mobile, which is expected to result in revenue and profit declines. Following these developments, Oppenheimer downgraded Amdocs from \"Outperform\" to \"Perform,\" citing the weak guidance and ongoing customer dispute as the main reasons for the downgrade.\n\nAs a result, Amdocs has gained significant attention from investors, who are closely monitoring the situation. The stock's recent performance and developments surrounding the company present an interesting case study for market observers.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}